25 XP   0   0   10

Icares Medicus Inc
Buy, Hold or Sell?

Let's analyse Icares Medicus Inc together

PenkeI guess you are interested in Icares Medicus Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Icares Medicus Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Icares Medicus Inc

I send you an email if I find something interesting about Icares Medicus Inc.

Quick analysis of Icares Medicus Inc (30 sec.)










What can you expect buying and holding a share of Icares Medicus Inc? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
53.3%

What is your share worth?

Current worth
NT$43.57
Expected worth in 1 year
NT$63.34
How sure are you?
93.3%

+ What do you gain per year?

Total Gains per Share
NT$19.77
Return On Investment
11.2%

For what price can you sell your share?

Current Price per Share
NT$176.50
Expected price per share
NT$154.00 - NT$198.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Icares Medicus Inc (5 min.)




Live pricePrice per Share (EOD)

NT$176.50

Intrinsic Value Per Share

NT$-5.00 - NT$-6.00

Total Value Per Share

NT$38.57 - NT$37.57

2. Growth of Icares Medicus Inc (5 min.)




Is Icares Medicus Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$52.5m$28.1m$13.9m33.1%

How much money is Icares Medicus Inc making?

Current yearPrevious yearGrowGrow %
Making money$728.3k$965.6k-$237.2k-32.6%
Net Profit Margin14.7%23.4%--

How much money comes from the company's main activities?

3. Financial Health of Icares Medicus Inc (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#120 / 168

Most Revenue
#134 / 168

Most Profit
#98 / 168
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Icares Medicus Inc? (5 min.)

Welcome investor! Icares Medicus Inc's management wants to use your money to grow the business. In return you get a share of Icares Medicus Inc.

What can you expect buying and holding a share of Icares Medicus Inc?

First you should know what it really means to hold a share of Icares Medicus Inc. And how you can make/lose money.

Speculation

The Price per Share of Icares Medicus Inc is NT$176.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Icares Medicus Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Icares Medicus Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$43.57. Based on the TTM, the Book Value Change Per Share is NT$4.94 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.70 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Icares Medicus Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.020.0%0.020.0%0.030.0%0.020.0%0.020.0%
Usd Book Value Change Per Share0.030.0%0.150.1%0.020.0%0.090.1%0.090.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.030.0%0.150.1%0.020.0%0.090.1%0.090.1%
Usd Price Per Share3.42-4.19-2.86-2.86-2.86-
Price to Earnings Ratio47.14--17.58-27.51--33.61--33.61-
Price-to-Total Gains Ratio116.20-77.89--68.39-81.48-81.48-
Price to Book Ratio2.55-4.28-3.97-3.87-3.87-
Price-to-Total Gains Ratio116.20-77.89--68.39-81.48-81.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.4362
Number of shares183
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.150.09
Usd Total Gains Per Share0.150.09
Gains per Quarter (183 shares)27.8517.15
Gains per Year (183 shares)111.4268.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1011110136559
202232126131128
303343239196197
4044643412262266
5055754516327335
6066865619393404
7078076722458473
8089187825524542
90100398928589611
1001114110031655680

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%13.02.00.086.7%13.02.00.086.7%13.02.00.086.7%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%14.01.00.093.3%14.01.00.093.3%14.01.00.093.3%
Dividend per Share0.00.04.00.0%5.00.07.041.7%8.00.07.053.3%8.00.07.053.3%8.00.07.053.3%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%14.01.00.093.3%14.01.00.093.3%14.01.00.093.3%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Icares Medicus Inc

About Icares Medicus Inc

ICARES Medicus, Inc., a nano-medical material company, focuses on the research and development, manufacture, and sale of ophthalmic medical materials in Taiwan and internationally. It provides ophthalmic medical materials, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, or astigmatism; and surgical implantation systems, as well as related technical services. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei, Taiwan.

Fundamental data was last updated by Penke on 2024-06-27 04:39:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Icares Medicus Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Icares Medicus Inc earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Icares Medicus Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 14.3% means that NT$0.14 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Icares Medicus Inc:

  • The MRQ is 14.3%. The company is making a huge profit. +2
  • The TTM is 14.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.3%TTM14.7%-0.4%
TTM14.7%YOY23.4%-8.7%
TTM14.7%5Y17.1%-2.4%
5Y17.1%10Y17.1%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3%5.9%+8.4%
TTM14.7%6.5%+8.2%
YOY23.4%5.5%+17.9%
5Y17.1%7.2%+9.9%
10Y17.1%6.9%+10.2%
1.1.2. Return on Assets

Shows how efficient Icares Medicus Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Icares Medicus Inc to the Medical Instruments & Supplies industry mean.
  • 1.2% Return on Assets means that Icares Medicus Inc generated NT$0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Icares Medicus Inc:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.7%-0.5%
TTM1.7%YOY2.9%-1.2%
TTM1.7%5Y2.0%-0.3%
5Y2.0%10Y2.0%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%0.8%+0.4%
TTM1.7%1.0%+0.7%
YOY2.9%1.4%+1.5%
5Y2.0%1.5%+0.5%
10Y2.0%1.6%+0.4%
1.1.3. Return on Equity

Shows how efficient Icares Medicus Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Icares Medicus Inc to the Medical Instruments & Supplies industry mean.
  • 1.4% Return on Equity means Icares Medicus Inc generated NT$0.01 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Icares Medicus Inc:

  • The MRQ is 1.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.4%TTM2.3%-0.9%
TTM2.3%YOY3.7%-1.4%
TTM2.3%5Y2.6%-0.3%
5Y2.6%10Y2.6%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4%1.5%-0.1%
TTM2.3%1.9%+0.4%
YOY3.7%2.7%+1.0%
5Y2.6%3.1%-0.5%
10Y2.6%2.8%-0.2%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Icares Medicus Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Icares Medicus Inc is operating .

  • Measures how much profit Icares Medicus Inc makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Icares Medicus Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Icares Medicus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.2%-6.2%
TTM6.2%YOY16.8%-10.6%
TTM6.2%5Y16.4%-10.2%
5Y16.4%10Y16.4%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM6.2%4.9%+1.3%
YOY16.8%8.9%+7.9%
5Y16.4%9.5%+6.9%
10Y16.4%9.6%+6.8%
1.2.2. Operating Ratio

Measures how efficient Icares Medicus Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are NT$0.97 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Icares Medicus Inc:

  • The MRQ is 0.974. The company is less efficient in keeping operating costs low.
  • The TTM is 1.013. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.974TTM1.013-0.040
TTM1.013YOY0.956+0.057
TTM1.0135Y0.972+0.042
5Y0.97210Y0.9720.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9741.086-0.112
TTM1.0131.112-0.099
YOY0.9561.153-0.197
5Y0.9721.084-0.112
10Y0.9721.057-0.085
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Icares Medicus Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Icares Medicus Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 8.46 means the company has NT$8.46 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Icares Medicus Inc:

  • The MRQ is 8.462. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.015. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.462TTM7.015+1.447
TTM7.015YOY4.872+2.143
TTM7.0155Y5.573+1.442
5Y5.57310Y5.5730.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ8.4622.200+6.262
TTM7.0152.310+4.705
YOY4.8722.538+2.334
5Y5.5732.659+2.914
10Y5.5732.630+2.943
1.3.2. Quick Ratio

Measures if Icares Medicus Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Icares Medicus Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 4.69 means the company can pay off NT$4.69 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Icares Medicus Inc:

  • The MRQ is 4.691. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.573. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.691TTM3.573+1.118
TTM3.573YOY1.746+1.826
TTM3.5735Y1.834+1.739
5Y1.83410Y1.8340.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6910.983+3.708
TTM3.5730.983+2.590
YOY1.7461.162+0.584
5Y1.8341.344+0.490
10Y1.8341.502+0.332
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Icares Medicus Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Icares Medicus Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Icares Medicus Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.15 means that Icares Medicus Inc assets are financed with 14.6% credit (debt) and the remaining percentage (100% - 14.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Icares Medicus Inc:

  • The MRQ is 0.146. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.181. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.146TTM0.181-0.036
TTM0.181YOY0.150+0.031
TTM0.1815Y0.170+0.011
5Y0.17010Y0.1700.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1460.360-0.214
TTM0.1810.357-0.176
YOY0.1500.344-0.194
5Y0.1700.361-0.191
10Y0.1700.371-0.201
1.4.2. Debt to Equity Ratio

Measures if Icares Medicus Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Icares Medicus Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 17.9% means that company has NT$0.18 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Icares Medicus Inc:

  • The MRQ is 0.179. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.244. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.179TTM0.244-0.065
TTM0.244YOY0.192+0.053
TTM0.2445Y0.222+0.022
5Y0.22210Y0.2220.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1790.541-0.362
TTM0.2440.564-0.320
YOY0.1920.525-0.333
5Y0.2220.627-0.405
10Y0.2220.659-0.437
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Icares Medicus Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Icares Medicus Inc generates.

  • Above 15 is considered overpriced but always compare Icares Medicus Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 47.14 means the investor is paying NT$47.14 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Icares Medicus Inc:

  • The EOD is 74.956. Based on the earnings, the company is expensive. -2
  • The MRQ is 47.139. Based on the earnings, the company is overpriced. -1
  • The TTM is -17.575. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD74.956MRQ47.139+27.816
MRQ47.139TTM-17.575+64.715
TTM-17.575YOY27.510-45.085
TTM-17.5755Y-33.609+16.033
5Y-33.60910Y-33.6090.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD74.95616.706+58.250
MRQ47.13916.779+30.360
TTM-17.57517.405-34.980
YOY27.51020.032+7.478
5Y-33.60921.106-54.715
10Y-33.60927.678-61.287
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Icares Medicus Inc:

  • The EOD is -132.603. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -83.394. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -69.486. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-132.603MRQ-83.394-49.210
MRQ-83.394TTM-69.486-13.908
TTM-69.486YOY10.863-80.349
TTM-69.4865Y84.672-154.158
5Y84.67210Y84.6720.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-132.603-0.755-131.848
MRQ-83.394-0.497-82.897
TTM-69.4863.525-73.011
YOY10.8632.618+8.245
5Y84.6726.512+78.160
10Y84.6721.540+83.132
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Icares Medicus Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 2.55 means the investor is paying NT$2.55 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Icares Medicus Inc:

  • The EOD is 4.051. Based on the equity, the company is fair priced.
  • The MRQ is 2.548. Based on the equity, the company is underpriced. +1
  • The TTM is 4.281. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.051MRQ2.548+1.503
MRQ2.548TTM4.281-1.734
TTM4.281YOY3.971+0.311
TTM4.2815Y3.865+0.416
5Y3.86510Y3.8650.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD4.0512.460+1.591
MRQ2.5482.628-0.080
TTM4.2812.686+1.595
YOY3.9712.954+1.017
5Y3.8653.958-0.093
10Y3.8654.442-0.577
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Icares Medicus Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.9554.942-81%0.696+37%2.905-67%2.905-67%
Book Value Per Share--43.57134.867+25%23.327+87%24.449+78%24.449+78%
Current Ratio--8.4627.015+21%4.872+74%5.573+52%5.573+52%
Debt To Asset Ratio--0.1460.181-20%0.150-3%0.170-14%0.170-14%
Debt To Equity Ratio--0.1790.244-27%0.192-7%0.222-19%0.222-19%
Dividend Per Share----0%0.108-100%0.139-100%0.139-100%
Eps--0.5890.604-3%0.891-34%0.586+0%0.586+0%
Free Cash Flow Per Share---0.333-0.800+140%0.632-153%0.051-757%0.051-757%
Free Cash Flow To Equity Per Share---0.333-0.800+140%0.493-168%0.055-709%0.055-709%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6.002--------
Intrinsic Value_10Y_min---5.003--------
Intrinsic Value_1Y_max---0.137--------
Intrinsic Value_1Y_min---0.134--------
Intrinsic Value_3Y_max---0.766--------
Intrinsic Value_3Y_min---0.724--------
Intrinsic Value_5Y_max---1.821--------
Intrinsic Value_5Y_min---1.660--------
Market Cap6911810600.000+37%4346804400.0005325814400.000-18%3634085120.000+20%3637217952.000+20%3637217952.000+20%
Net Profit Margin--0.1430.147-3%0.234-39%0.171-16%0.171-16%
Operating Margin---0.062-100%0.168-100%0.164-100%0.164-100%
Operating Ratio--0.9741.013-4%0.956+2%0.972+0%0.972+0%
Pb Ratio4.051+37%2.5484.281-40%3.971-36%3.865-34%3.865-34%
Pe Ratio74.956+37%47.139-17.575+137%27.510+71%-33.609+171%-33.609+171%
Price Per Share176.500+37%111.000136.000-18%92.800+20%92.880+20%92.880+20%
Price To Free Cash Flow Ratio-132.603-59%-83.394-69.486-17%10.863-868%84.672-198%84.672-198%
Price To Total Gains Ratio184.763+37%116.19777.887+49%-68.391+159%81.476+43%81.476+43%
Quick Ratio--4.6913.573+31%1.746+169%1.834+156%1.834+156%
Return On Assets--0.0120.017-31%0.029-60%0.020-42%0.020-42%
Return On Equity--0.0140.023-38%0.037-61%0.026-46%0.026-46%
Total Gains Per Share--0.9554.942-81%0.804+19%3.043-69%3.043-69%
Usd Book Value--52553054.40042054343.100+25%28135499.700+87%29488494.933+78%29488494.933+78%
Usd Book Value Change Per Share--0.0290.152-81%0.021+37%0.089-67%0.089-67%
Usd Book Value Per Share--1.3421.074+25%0.718+87%0.753+78%0.753+78%
Usd Dividend Per Share----0%0.003-100%0.004-100%0.004-100%
Usd Eps--0.0180.019-3%0.027-34%0.018+0%0.018+0%
Usd Free Cash Flow---401354.800-964486.600+140%761707.100-153%61129.787-757%61129.787-757%
Usd Free Cash Flow Per Share---0.010-0.025+140%0.019-153%0.002-757%0.002-757%
Usd Free Cash Flow To Equity Per Share---0.010-0.025+140%0.015-168%0.002-709%0.002-709%
Usd Market Cap212883766.480+37%133881575.520164035083.520-18%111929821.696+20%112026312.922+20%112026312.922+20%
Usd Price Per Share5.436+37%3.4194.189-18%2.858+20%2.861+20%2.861+20%
Usd Profit--710032.400728350.700-3%965618.500-26%677760.160+5%677760.160+5%
Usd Revenue--4958830.8004758954.200+4%4166747.200+19%3775542.027+31%3775542.027+31%
Usd Total Gains Per Share--0.0290.152-81%0.025+19%0.094-69%0.094-69%
 EOD+5 -3MRQTTM+18 -15YOY+18 -175Y+17 -1810Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of Icares Medicus Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1574.956
Price to Book Ratio (EOD)Between0-14.051
Net Profit Margin (MRQ)Greater than00.143
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.691
Current Ratio (MRQ)Greater than18.462
Debt to Asset Ratio (MRQ)Less than10.146
Debt to Equity Ratio (MRQ)Less than10.179
Return on Equity (MRQ)Greater than0.150.014
Return on Assets (MRQ)Greater than0.050.012
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Icares Medicus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose178.500
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets1,997,002
Total Liabilities290,734
Total Stockholder Equity1,623,306
 As reported
Total Liabilities 290,734
Total Stockholder Equity+ 1,623,306
Total Assets = 1,997,002

Assets

Total Assets1,997,002
Total Current Assets1,344,220
Long-term Assets652,782
Total Current Assets
Cash And Cash Equivalents 402,942
Short-term Investments 571,774
Net Receivables 173,303
Inventory 148,455
Other Current Assets 42,321
Total Current Assets  (as reported)1,344,220
Total Current Assets  (calculated)1,338,795
+/- 5,425
Long-term Assets
Property Plant Equipment 266,597
Long-term Assets Other 126,551
Long-term Assets  (as reported)652,782
Long-term Assets  (calculated)393,148
+/- 259,634

Liabilities & Shareholders' Equity

Total Current Liabilities158,846
Long-term Liabilities131,888
Total Stockholder Equity1,623,306
Total Current Liabilities
Accounts payable 8,649
Other Current Liabilities 412
Total Current Liabilities  (as reported)158,846
Total Current Liabilities  (calculated)9,061
+/- 149,785
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt142,354
Long-term Liabilities  (as reported)131,888
Long-term Liabilities  (calculated)142,354
+/- 10,466
Total Stockholder Equity
Retained Earnings 386,012
Total Stockholder Equity (as reported)1,623,306
Total Stockholder Equity (calculated)386,012
+/- 1,237,294
Other
Capital Stock391,604
Common Stock Shares Outstanding 39,160
Net Invested Capital 1,623,306
Net Working Capital 1,185,374
Property Plant and Equipment Gross 266,597



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
841,358
848,046
875,641
882,282
940,412
965,866
998,080
1,017,005
1,112,772
1,043,411
1,130,806
1,203,517
1,511,547
1,908,658
1,997,002
1,997,0021,908,6581,511,5471,203,5171,130,8061,043,4111,112,7721,017,005998,080965,866940,412882,282875,641848,046841,358
   > Total Current Assets 
432,274
422,499
456,759
469,754
539,169
556,879
588,349
572,754
663,754
660,948
697,109
663,838
915,937
1,293,040
1,344,220
1,344,2201,293,040915,937663,838697,109660,948663,754572,754588,349556,879539,169469,754456,759422,499432,274
       Cash And Cash Equivalents 
288,359
281,341
300,997
302,109
343,373
356,257
377,508
375,032
301,072
284,591
325,626
259,879
332,965
381,265
402,942
402,942381,265332,965259,879325,626284,591301,072375,032377,508356,257343,373302,109300,997281,341288,359
       Short-term Investments 
0
0
0
0
0
17,376
13,518
13,317
146,769
142,294
112,721
115,656
206,543
587,174
571,774
571,774587,174206,543115,656112,721142,294146,76913,31713,51817,37600000
       Net Receivables 
75,162
65,083
73,643
79,432
87,873
89,884
111,479
105,622
113,781
132,409
143,081
157,707
165,722
136,715
173,303
173,303136,715165,722157,707143,081132,409113,781105,622111,47989,88487,87379,43273,64365,08375,162
       Inventory 
46,356
49,101
52,141
54,229
61,710
58,610
59,447
62,258
77,773
79,360
84,159
104,036
120,463
129,683
148,455
148,455129,683120,463104,03684,15979,36077,77362,25859,44758,61061,71054,22952,14149,10146,356
       Other Current Assets 
22,397
26,974
29,978
33,984
46,213
52,128
26,397
16,525
24,359
22,294
22,903
26,560
37,140
40,416
42,321
42,32140,41637,14026,56022,90322,29424,35916,52526,39752,12846,21333,98429,97826,97422,397
   > Long-term Assets 
409,084
425,547
418,882
412,528
401,243
408,987
409,731
444,251
449,018
382,463
433,697
539,679
595,610
615,618
652,782
652,782615,618595,610539,679433,697382,463449,018444,251409,731408,987401,243412,528418,882425,547409,084
       Property Plant Equipment 
123,589
120,679
115,733
114,681
109,860
106,669
109,282
107,154
107,076
100,617
143,748
213,700
237,375
237,774
266,597
266,597237,774237,375213,700143,748100,617107,076107,154109,282106,669109,860114,681115,733120,679123,589
       Other Assets 
15,475
17,506
14,638
9,164
7,603
7,107
37,001
39,253
34,297
47,906
0
84,425
0
0
0
00084,425047,90634,29739,25337,0017,1077,6039,16414,63817,50615,475
> Total Liabilities 
147,677
145,621
167,692
171,630
153,520
144,963
174,866
164,703
181,049
105,647
198,634
226,899
401,689
239,799
290,734
290,734239,799401,689226,899198,634105,647181,049164,703174,866144,963153,520171,630167,692145,621147,677
   > Total Current Liabilities 
75,302
63,331
85,973
86,511
126,108
115,865
154,315
148,145
164,423
93,004
155,647
113,207
278,879
123,736
158,846
158,846123,736278,879113,207155,64793,004164,423148,145154,315115,865126,10886,51185,97363,33175,302
       Accounts payable 
3,655
2,928
7,813
5,490
3,856
3,816
5,364
7,676
9,050
7,490
13,367
13,264
7,962
5,734
8,649
8,6495,7347,96213,26413,3677,4909,0507,6765,3643,8163,8565,4907,8132,9283,655
       Other Current Liabilities 
64,600
53,196
70,926
72,473
113,635
103,306
140,037
131,729
147,655
79,309
15,303
84,266
10,868
546
412
41254610,86884,26615,30379,309147,655131,729140,037103,306113,63572,47370,92653,19664,600
   > Long-term Liabilities 
72,375
82,290
81,719
85,119
27,412
29,098
20,551
16,558
16,626
12,643
42,987
113,692
122,810
116,063
131,888
131,888116,063122,810113,69242,98712,64316,62616,55820,55129,09827,41285,11981,71982,29072,375
       Capital Lease Obligations Min Short Term Debt
21,882
20,418
18,561
18,885
16,766
14,717
12,825
10,722
8,495
6,159
41,894
116,037
128,988
121,636
142,354
142,354121,636128,988116,03741,8946,1598,49510,72212,82514,71716,76618,88518,56120,41821,882
       Other Liabilities 
54,599
66,201
67,509
71,967
16,449
20,327
13,747
11,527
12,595
12,643
0
13,286
0
0
0
00013,286012,64312,59511,52713,74720,32716,44971,96767,50966,20154,599
> Total Stockholder Equity
652,836
665,840
676,469
684,509
707,477
746,784
751,481
784,349
867,127
878,747
871,325
923,222
1,003,859
1,577,962
1,623,306
1,623,3061,577,9621,003,859923,222871,325878,747867,127784,349751,481746,784707,477684,509676,469665,840652,836
   Common Stock
337,319
337,319
339,699
339,699
339,699
339,699
339,699
339,639
341,639
341,639
0
341,639
0
0
0
000341,6390341,639341,639339,639339,699339,699339,699339,699339,699337,319337,319
   Retained Earnings 
186,575
185,852
188,638
197,172
214,856
241,058
253,770
281,107
329,649
352,984
312,144
385,368
377,132
370,791
386,012
386,012370,791377,132385,368312,144352,984329,649281,107253,770241,058214,856197,172188,638185,852186,575
   Accumulated Other Comprehensive Income 000000000000000
   Capital Surplus 000000000000000
   Treasury Stock000000000000000



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue605,452
Cost of Revenue-123,050
Gross Profit482,402482,402
 
Operating Income (+$)
Gross Profit482,402
Operating Expense-486,809
Operating Income118,643-4,407
 
Operating Expense (+$)
Research Development177,446
Selling General Administrative186,313
Selling And Marketing Expenses0
Operating Expense486,809363,759
 
Net Interest Income (+$)
Interest Income2,377
Interest Expense-7,171
Other Finance Cost-0
Net Interest Income-4,794
 
Pretax Income (+$)
Operating Income118,643
Net Interest Income-4,794
Other Non-Operating Income Expenses0
Income Before Tax (EBT)113,290118,643
EBIT - interestExpense = -7,171
97,729
104,900
Interest Expense7,171
Earnings Before Interest and Taxes (EBIT)0120,461
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax113,290
Tax Provision-48,859
Net Income From Continuing Ops64,43164,431
Net Income97,729
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net04,794
 

Technical Analysis of Icares Medicus Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Icares Medicus Inc. The general trend of Icares Medicus Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Icares Medicus Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Icares Medicus Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 176.50 < 181.50 < 198.50.

The bearish price targets are: 168.00 > 160.50 > 154.00.

Tweet this
Icares Medicus Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Icares Medicus Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Icares Medicus Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Icares Medicus Inc.

Icares Medicus Inc Daily Moving Average Convergence/Divergence (MACD) ChartIcares Medicus Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Icares Medicus Inc. The current adx is .

Icares Medicus Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Icares Medicus Inc.

Icares Medicus Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Icares Medicus Inc.

Icares Medicus Inc Daily Relative Strength Index (RSI) ChartIcares Medicus Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Icares Medicus Inc.

Icares Medicus Inc Daily Stochastic Oscillator ChartIcares Medicus Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Icares Medicus Inc.

Icares Medicus Inc Daily Commodity Channel Index (CCI) ChartIcares Medicus Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Icares Medicus Inc.

Icares Medicus Inc Daily Chande Momentum Oscillator (CMO) ChartIcares Medicus Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Icares Medicus Inc.

Icares Medicus Inc Daily Williams %R ChartIcares Medicus Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Icares Medicus Inc.

Icares Medicus Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Icares Medicus Inc.

Icares Medicus Inc Daily Average True Range (ATR) ChartIcares Medicus Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Icares Medicus Inc.

Icares Medicus Inc Daily On-Balance Volume (OBV) ChartIcares Medicus Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Icares Medicus Inc.

Icares Medicus Inc Daily Money Flow Index (MFI) ChartIcares Medicus Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Icares Medicus Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-05-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Icares Medicus Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Icares Medicus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose178.500
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Icares Medicus Inc with someone you think should read this too:
  • Are you bullish or bearish on Icares Medicus Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Icares Medicus Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Icares Medicus Inc

I send you an email if I find something interesting about Icares Medicus Inc.


Stay informed about Icares Medicus Inc.

Receive notifications about Icares Medicus Inc in your mailbox!